ID

37385

Description

Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT02242149

Lien

https://clinicaltrials.gov/show/NCT02242149

Mots-clés

Versions (1)
  1. 21/07/2019 21/07/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

21 juillet 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Type 2 Diabetes. NCT02242149

Anglais

Eligibility Type 2 Diabetes. NCT02242149

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes.
Description

Diabetes Mellitus, Non-Insulin-Dependent

Type de données

boolean

Alias
UMLS CUI [1]
C0011860
presence of liver steatosis diagnosed by ultrasound or transient elastography (fibroscan®)
Description

Fatty Liver Ultrasonography | Fatty Liver Transient elastography | Fatty Liver Fibroscan

Type de données

boolean

Alias
UMLS CUI [1,1]
C0015695
UMLS CUI [1,2]
C0041618
UMLS CUI [2,1]
C0015695
UMLS CUI [2,2]
C2748260
UMLS CUI [3,1]
C0015695
UMLS CUI [3,2]
C4522043
age 30-75 years.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
hba1c 7.5- 9.5 for at least 8 weeks prior to screening.
Description

Hemoglobin A1c measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0474680
stable diabetes therapeutic regimen consisting of either diet, oral hypoglycemic agents with or without insulin for 8 weeks prior to randomization.
Description

Diabetes Therapy Stable | Diet therapy | Oral hypoglycemic | Insulin | Insulin Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C3274787
UMLS CUI [1,2]
C0205360
UMLS CUI [2]
C0012159
UMLS CUI [3]
C0359086
UMLS CUI [4]
C0021641
UMLS CUI [5,1]
C0021641
UMLS CUI [5,2]
C0332197
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
body mass index > 40 kg/m2
Description

Body mass index

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
serum creatinine ≥180mmol/l or estimated glomerular filtration rate < 30 ml/min.
Description

Creatinine measurement, serum | Estimated Glomerular Filtration Rate

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C3811844
presence of any serious concomitant disease, such as a pulmonary disease or malignant disorders.
Description

Comorbidity Serious | Lung disease | Malignant disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205404
UMLS CUI [2]
C0024115
UMLS CUI [3]
C0442867
current daily alcohol ingestion ≥20 g.
Description

Alcohol consumption g/day

Type de données

boolean

Alias
UMLS CUI [1,1]
C0001948
UMLS CUI [1,2]
C0439417
hepatotoxic drugs.
Description

Pharmaceutical Preparations Hepatotoxic effect

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0235378
presence of other chronic liver disease other than nonalcoholic fatty liver disease, including hepatitis b virus and hepatitis c virus infection, hemochromatosis, wilson's disease, alfa-1 antitrypsin deficiency, autoimmune hepatitis.
Description

Chronic liver disease | Exception Non-alcoholic Fatty Liver Disease | Hepatitis B | Hepatitis C | Hemochromatosis | Wilson's disease | alpha 1-Antitrypsin Deficiency | Hepatitis Autoimmune

Type de données

boolean

Alias
UMLS CUI [1]
C0341439
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0400966
UMLS CUI [3]
C0019163
UMLS CUI [4]
C0019196
UMLS CUI [5]
C0018995
UMLS CUI [6]
C0019202
UMLS CUI [7]
C0221757
UMLS CUI [8,1]
C0019158
UMLS CUI [8,2]
C0004364
women seeking pregnancy.
Description

Gender | Pregnancy, Planned

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0032992
current use or previous use within 6 months of vitamin e or pioglitazone
Description

Vitamin E | pioglitazone

Type de données

boolean

Alias
UMLS CUI [1]
C0042874
UMLS CUI [2]
C0071097
Retour au début de la page

Similar models

Eligibility Type 2 Diabetes. NCT02242149

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes.
boolean
C0011860 (UMLS CUI [1])
Fatty Liver Ultrasonography | Fatty Liver Transient elastography | Fatty Liver Fibroscan
Item
presence of liver steatosis diagnosed by ultrasound or transient elastography (fibroscan®)
boolean
C0015695 (UMLS CUI [1,1])
C0041618 (UMLS CUI [1,2])
C0015695 (UMLS CUI [2,1])
C2748260 (UMLS CUI [2,2])
C0015695 (UMLS CUI [3,1])
C4522043 (UMLS CUI [3,2])
Age
Item
age 30-75 years.
boolean
C0001779 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
hba1c 7.5- 9.5 for at least 8 weeks prior to screening.
boolean
C0474680 (UMLS CUI [1])
Diabetes Therapy Stable | Diet therapy | Oral hypoglycemic | Insulin | Insulin Absent
Item
stable diabetes therapeutic regimen consisting of either diet, oral hypoglycemic agents with or without insulin for 8 weeks prior to randomization.
boolean
C3274787 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0012159 (UMLS CUI [2])
C0359086 (UMLS CUI [3])
C0021641 (UMLS CUI [4])
C0021641 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
Item Group
C0680251 (UMLS CUI)
Body mass index
Item
body mass index > 40 kg/m2
boolean
C1305855 (UMLS CUI [1])
Creatinine measurement, serum | Estimated Glomerular Filtration Rate
Item
serum creatinine ≥180mmol/l or estimated glomerular filtration rate < 30 ml/min.
boolean
C0201976 (UMLS CUI [1])
C3811844 (UMLS CUI [2])
Comorbidity Serious | Lung disease | Malignant disease
Item
presence of any serious concomitant disease, such as a pulmonary disease or malignant disorders.
boolean
C0009488 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0024115 (UMLS CUI [2])
C0442867 (UMLS CUI [3])
Alcohol consumption g/day
Item
current daily alcohol ingestion ≥20 g.
boolean
C0001948 (UMLS CUI [1,1])
C0439417 (UMLS CUI [1,2])
Pharmaceutical Preparations Hepatotoxic effect
Item
hepatotoxic drugs.
boolean
C0013227 (UMLS CUI [1,1])
C0235378 (UMLS CUI [1,2])
Chronic liver disease | Exception Non-alcoholic Fatty Liver Disease | Hepatitis B | Hepatitis C | Hemochromatosis | Wilson's disease | alpha 1-Antitrypsin Deficiency | Hepatitis Autoimmune
Item
presence of other chronic liver disease other than nonalcoholic fatty liver disease, including hepatitis b virus and hepatitis c virus infection, hemochromatosis, wilson's disease, alfa-1 antitrypsin deficiency, autoimmune hepatitis.
boolean
C0341439 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0400966 (UMLS CUI [2,2])
C0019163 (UMLS CUI [3])
C0019196 (UMLS CUI [4])
C0018995 (UMLS CUI [5])
C0019202 (UMLS CUI [6])
C0221757 (UMLS CUI [7])
C0019158 (UMLS CUI [8,1])
C0004364 (UMLS CUI [8,2])
Gender | Pregnancy, Planned
Item
women seeking pregnancy.
boolean
C0079399 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
Vitamin E | pioglitazone
Item
current use or previous use within 6 months of vitamin e or pioglitazone
boolean
C0042874 (UMLS CUI [1])
C0071097 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial